{"id":"dfd-03-lotion-0-1","_chembl":{"chemblId":"CHEMBL2108158","moleculeType":"Unknown"},"modality":"Small molecule","_dailymed":null,"_scrapedAt":"2026-03-28T02:32:27.685Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_claudeStub":{"ts":1779123234,"model":"claude-sonnet-4-5-20250929"},"description":"DFD-03 Lotion, 0.1% is an investigational topical formulation developed by Dr. Reddy's Laboratories for dermatological conditions. Currently in Phase 2 clinical development, this lotion represents the company's effort to expand its dermatology portfolio with a novel topical treatment approach.","indications":{"approved":[{"status":"investigational","condition":"Dermatological condition (specific indication unknown)","patientPopulation":"Unknown"}]},"trialDetails":[{"nctId":"NCT03292640","phase":"PHASE3","title":"A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2017-07-06","conditions":"Acne Vulgaris","enrollment":547},{"nctId":"NCT03290027","phase":"PHASE3","title":"A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2017-07-31","conditions":"Acne Vulgaris","enrollment":550},{"nctId":"NCT03599193","phase":"PHASE2","title":"A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne Vulgaris","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2017-10-04","conditions":"Acne Vulgaris","enrollment":58},{"nctId":"NCT03341910","phase":"PHASE2","title":"A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® Cream, 0.1% in the Topical Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2017-08-21","conditions":"Acne Vulgaris","enrollment":155}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Tazarotene Lotion, 0.1%"],"phase":"phase_2","status":"active","brandName":"DFD-03 Lotion, 0.1%","genericName":"DFD-03 Lotion, 0.1%","companyName":"Dr. Reddy's Laboratories Limited","companyId":"dr-reddy-s-laboratories-limited","firstApprovalDate":"","aiSummary":"DFD-03 Lotion, 0.1%, is a topical treatment being studied for the safety and local tolerability in the treatment of Acne Vulgaris. The exact mechanism of DFD-03 Lotion, 0.1%, is currently unknown.","enrichmentLevel":2,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}